DE2148452C3 - Verwendung einer wasserunlöslichen Protoplastmembranfraktion aus haemolytischen Streptococcen mit tumorstatischer Wirkung bei der Bekämpfung maligner Geschwulste - Google Patents

Verwendung einer wasserunlöslichen Protoplastmembranfraktion aus haemolytischen Streptococcen mit tumorstatischer Wirkung bei der Bekämpfung maligner Geschwulste

Info

Publication number
DE2148452C3
DE2148452C3 DE2148452A DE2148452A DE2148452C3 DE 2148452 C3 DE2148452 C3 DE 2148452C3 DE 2148452 A DE2148452 A DE 2148452A DE 2148452 A DE2148452 A DE 2148452A DE 2148452 C3 DE2148452 C3 DE 2148452C3
Authority
DE
Germany
Prior art keywords
cells
tumor
water
streptococci
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2148452A
Other languages
German (de)
English (en)
Other versions
DE2148452B2 (de
DE2148452A1 (de
Inventor
Shigeo Suzuki
Akihiro Higashimurayama Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE2148452A1 publication Critical patent/DE2148452A1/de
Publication of DE2148452B2 publication Critical patent/DE2148452B2/de
Application granted granted Critical
Publication of DE2148452C3 publication Critical patent/DE2148452C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DE2148452A 1970-09-30 1971-09-28 Verwendung einer wasserunlöslichen Protoplastmembranfraktion aus haemolytischen Streptococcen mit tumorstatischer Wirkung bei der Bekämpfung maligner Geschwulste Expired DE2148452C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45085006A JPS496096B1 (cg-RX-API-DMAC10.html) 1970-09-30 1970-09-30

Publications (3)

Publication Number Publication Date
DE2148452A1 DE2148452A1 (de) 1972-04-06
DE2148452B2 DE2148452B2 (de) 1981-04-02
DE2148452C3 true DE2148452C3 (de) 1982-04-01

Family

ID=13846635

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2148452A Expired DE2148452C3 (de) 1970-09-30 1971-09-28 Verwendung einer wasserunlöslichen Protoplastmembranfraktion aus haemolytischen Streptococcen mit tumorstatischer Wirkung bei der Bekämpfung maligner Geschwulste

Country Status (7)

Country Link
US (1) US3786141A (cg-RX-API-DMAC10.html)
JP (1) JPS496096B1 (cg-RX-API-DMAC10.html)
CA (1) CA971895A (cg-RX-API-DMAC10.html)
CH (1) CH567421A5 (cg-RX-API-DMAC10.html)
DE (1) DE2148452C3 (cg-RX-API-DMAC10.html)
FR (1) FR2108094B1 (cg-RX-API-DMAC10.html)
GB (1) GB1333996A (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925160A (en) * 1974-09-26 1975-12-09 Univ Creighton Method of producing an antibiotic
JPS51133489A (en) * 1975-05-14 1976-11-19 Tokyo Daigaku Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation
JPS5679622A (en) * 1979-12-04 1981-06-30 Kanebo Ltd Antitumor pharmaceutical
US5061695A (en) * 1989-01-30 1991-10-29 Banyu Pharmaceutical Co., Ltd. Antitumor substance be-12406
US6406692B1 (en) * 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8144E (cg-RX-API-DMAC10.html) *
FR7480E (fr) * 1906-08-22 1907-08-09 Rodolphe Berthon Perfectionnements aux défileurs cinématographiques du commerce en vue de la projection en couleurs de films impressionnés au travers d'écrans sélecteurs trichromes
GB1132676A (en) * 1966-03-08 1968-11-06 Chugai Pharmaceutical Co Ltd Anti-tumour preparation and process for preparing the same
GB1153113A (en) * 1967-01-20 1969-05-21 Chugai Pharmaceutical Co Ltd Method of Treating Hemolytic Streptococci and the Resultant Preparation containing the same
GB1163865A (en) * 1967-02-01 1969-09-10 Kyowa Hakko Kogyo Kk Process for the preparation of Anti-Tumor Substances

Also Published As

Publication number Publication date
JPS496096B1 (cg-RX-API-DMAC10.html) 1974-02-12
CH567421A5 (cg-RX-API-DMAC10.html) 1975-10-15
DE2148452B2 (de) 1981-04-02
FR2108094A1 (cg-RX-API-DMAC10.html) 1972-05-12
DE2148452A1 (de) 1972-04-06
CA971895A (en) 1975-07-29
FR2108094B1 (cg-RX-API-DMAC10.html) 1975-10-10
US3786141A (en) 1974-01-15
GB1333996A (en) 1973-10-17

Similar Documents

Publication Publication Date Title
CH653556A5 (de) Arzneimittel mit antitumor-wirkung.
DE2659808C3 (de) Proteingebundene Polysaccharide und deren Verwendung zur Bekämpfung von Tumoren
DE3448148C2 (cg-RX-API-DMAC10.html)
DE2813353A1 (de) Substanz ks-2-a, verfahren zu deren herstellung und diese substanz enthaltendes mittel
DE2148452C3 (de) Verwendung einer wasserunlöslichen Protoplastmembranfraktion aus haemolytischen Streptococcen mit tumorstatischer Wirkung bei der Bekämpfung maligner Geschwulste
DE3134353C2 (de) Antibiotikum BMG162-aF2, Verfahren zu seiner Herstellung und dieses enthaltende Antitumormittel
DE2926406A1 (de) Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung
US4268505A (en) Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith
DE2623227A1 (de) Lucknomycin und verfahren zu seiner herstellung
DE1792390C3 (de) Verfahren zur Stabilisierung der carcinostatischen Wirksamkeit von Zellpräparaten haemolytischer, Streptolysin-S bildender Streptococcen
DE1919837B2 (de) Leupeptine, deren Salze und Verfahren zu ihrer Herstellung
CH657989A5 (de) Biologisch aktive substanz, verfahren zur herstellung der substanz, sowie die substanz enthaltende, immunoaktive zusammensetzung.
DE2146597A1 (de) Verfahren zum Stabilisieren eines Mikroorganismenzellen lyolysierenden Enzyms
DE1717100A1 (de) Verfahren zur Herstellung von anticarcinomatoesen Praeparaten haemolytischer Streptococcen
DE2816087A1 (de) Verwendung eines stickstoff enthaltenden polysaccharids zur foerderung der arzneimittelempfindlichkeit von gegen antibiotika resistenten bakterien
DE1208449B (de) Verfahren zur Herstellung des Antibiotikums Ussamycin
DE2809092A1 (de) Verfahren zur herstellung von emitanin
DE2856410C2 (de) Heptapeptide K 582 M-A und K 582 M-B, Verfahren zu ihrer Herstellung und diese Heptapeptide enthaltende Arzneimittel
DE1115888B (de) Verfahren zur Herstellung eines Streptokinase-Praeparates
DE2813282A1 (de) Pharmazeutische zusammensetzung auf basis lytischer enzyme von physarum
CH649709A5 (de) Antitumor-praeparat und verfahren zu dessen herstellung.
DE69222438T2 (de) Aids-virus-infektion hemmende zusammensetzung
DE1717100C (de) Verfahren zur Herstellung von Prapara ten hamolytischer Streptococcen zur unter stutzenden Behandlung von Carcinomerkrankun gen
DE2326943C3 (de) Xylostatsin Verfahren zu dessen Herstellung und Xylostatsin enthaltende Arzneimittel
DE3031152A1 (de) Carcinostatische substanzen, verfahren zur herstellung derselben und mittel mit einem gehalt derselben

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)